Avanir Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 15 of 15 Posts
Big Upcoming Catalysts For These 2 Small Biotechs
Article By: Bret Jensen Wednesday, April 29, 2015 3:36 AM EST
Protalix has a market capitalization of around $200 million, one fast growing approved product, and four other compounds in early development and the shares seem worthy of a small, speculative investment given upcoming catalysts.
In this article: AVNR, GSK, AGEN, MRK, PLX, INCY, PFE
Read
Buy These 3 Small Cap Rockets With Big Potential
Article By: Bret Jensen Tuesday, March 31, 2015 10:32 PM EST
Small cap stocks tend to have sharper swings, both up and down. It is very important to have a well-diversified portfolio of promising small cap stocks within one’s portfolio to mitigate volatility.
In this article: AVNR, EGRX, GLDD, CNAT, SGYP
Read
When Big Pharma Comes A-Calling: 3 Likely Takeover Targets For 2015
Article By: Bret Jensen Monday, February 23, 2015 5:14 AM EST
The small biotech and biopharma sectors has been very kind to my portfolio over the past six months.
In this article: AVNR, EGRX, TEVA, AGEN, INCY, GSK, HALO, BAX, JNJ, PFE
Read
2 More Triple Digit Winners In Biotech
Article By: Bret Jensen Monday, February 16, 2015 5:43 AM EST
The small cap biotech and biopharma complex has been very kind to everyone. Here are two more recommendations that have the signature Bret Jensen “X” factors that make up a great small cap biotech investment.
In this article: THLD, MSTX, AVNR, CRIS, ZIOP
Read
Our 3 Potential Triple Digit Biotech Winners Revisited
Article By: Bret Jensen Tuesday, February 10, 2015 2:29 PM EST
We’ve enjoyed a lot of success with biotechs lately, most notably Avanir that got bought out and gave Small Cap Gems subscribers a profit of 214.7% in only five months.
In this article: NAVB, INCY, AGEN, CRIS, AVNR
Read
Two Momentum Stocks With Triple Digit Potential
Article By: Bret Jensen Monday, January 26, 2015 2:56 PM EST
Today we’ll go over the two small cap plays within this niche that have me intrigued at the moment. Both companies have good prospects, market capitalizations of under $250 million and go for less than $10 a share.
In this article: DSCI, FCSC, GILD, CELG, AVNR
Read
Halozyme Therapeutics: A Good Bet To Get Back To Previous Highs
Article By: Bret Jensen Wednesday, January 21, 2015 4:23 AM EST
Halozyme is a San Diego-based biopharma company that develops human enzymes to enable or enhance subcutaneous drug delivery of biological drugs.
In this article: PFE, BAX, RHHBY, GILD, AVNR, HALO
Read
2 Upcoming Winners In 2015’s Hottest Sector
Article By: Bret Jensen Tuesday, January 13, 2015 2:32 PM EST
Biotech stocks are going to be big winners in 2015.
In this article: AVNR, CARA, GWPH, ZGNX
Read
Can Pharma ETFs Continue Their Uptrend In 2015?
Article By: Zacks Investment Research Sunday, January 11, 2015 12:42 PM EST
The worst of the patent cliff is over for the pharma sector which is slowly but steadily recovering from the impact of genericization. The NYSE ARCA Pharmaceutical Index is up 19.3% over the last year.
In this article: PJP, XPH, IHE, PPH, JNJ, MRK, PFE, NVS, AVNR, AUXL, LLY, GILD, CELG
Read
5 Best Performing Russell 2000 Stocks Of 2014
Article By: Zacks Investment Research Tuesday, December 23, 2014 11:13 AM EST
The Russell 2000 Index has lagged all the major benchmarks for most part of this year. As of Dec 22, the index has returned only 3.3%.
In this article: GTIV, UEIC, FLWS, SKH, AVNR, OVAS, RCPT, ACHN, TGTX, FOLD, PTX, AMRE
Read
2 Biotechs Under $5 That Will Light Up In 2015
Article By: Bret Jensen Friday, December 12, 2014 4:02 PM EST
Today we are going to talk about one of the most volatile – and often very rewarding — sectors of the market, the small cap biotech/biopharma space.
In this article: SGYP, AVNR, IRWD, ZIOP
Read
Otsuka Acquires Avanir Pharmaceuticals For $3.5 Billion
Article By: Terry Chrisomalis Tuesday, December 2, 2014 11:11 AM EST
Japanese pharma company to pay $17/share.
In this article: OTSKF, AVNR
Read
Otsuka Pharmaceutical To Acquire Avanir Pharmaceuticals
Article By: Business Wire Tuesday, December 2, 2014 9:04 AM EST
Otsuka Pharmaceutical Co., Ltd. is pleased to announce an agreement with Avanir Pharmaceuticals, Inc. in which Otsuka America, Inc., a US subsidiary, acquires Avanir for USD 3.5 billion in an all-cash tender offer.
In this article: AVNR
Read
Hot Bargains In Big Biotech
Article By: Bret Jensen Tuesday, November 18, 2014 12:00 PM EST
It has been an eventful year in the big pharma and biotech space, and a lot is happening in this space that biotech investors should take note of.
In this article: AGN, AVNR, REGN, AMGN, BIIB, CELG, GILD, ABBV
Read
Barchart Morning Call
Article By: Jim Van Meerten Wednesday, June 11, 2014 9:00 AM EST
June E-mini S&Ps (ESM14 -0.47%) this morning are down -0.40% and European stocks are down -0.64% after the World Bank cut its global 2014 GDP forecast to 2.8% from a Jan estimate of 3.2%.
In this article: CAT, COV, HRB, RAI, RSHC, RYN, SYK, TAP, TGI, AVNR, SBSA, MRVL, ULTA, REGI
Read
1 to 15 of 15 Posts